Cargando…

A Retrospective Study of the Efficacy of Albendazole and Diethylcarbamazine for the Treatment of Human Toxocariasis

In the Department of Parasitology and Mycology of Toulouse University Hospitals, patients presenting with common/covert toxocariasis were treated either with albendazole (39 cases) or with diethylcarbamazine (32 cases). Albendazole (ABZ) was given at 10 mg/kg b/w daily for 14 days, and diethylcarbam...

Descripción completa

Detalles Bibliográficos
Autores principales:	Magnaval, Jean-François, Fillaux, Judith, Berry, Antoine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317386/ https://www.ncbi.nlm.nih.gov/pubmed/35890057 http://dx.doi.org/10.3390/pathogens11070813

Ejemplares similares

Human toxocariasis and atopy
por: Magnaval, Jean-François, et al.
Publicado: (2020)

Therapy and Prevention for Human Toxocariasis
por: Magnaval, Jean-François, et al.
Publicado: (2022)

An open label, randomized clinical trial to compare the tolerability and efficacy of ivermectin plus diethylcarbamazine and albendazole vs. diethylcarbamazine plus albendazole for treatment of brugian filariasis in Indonesia
por: Supali, Taniawati, et al.
Publicado: (2021)

Pharmacokinetics of Moxidectin combined with Albendazole or Albendazole plus Diethylcarbamazine for Bancroftian Filariasis
por: Chhonker, Yashpal S., et al.
Publicado: (2023)

An open label, block randomized, community study of the safety and efficacy of co-administered ivermectin, diethylcarbamazine plus albendazole vs. diethylcarbamazine plus albendazole for lymphatic filariasis in India
por: Jambulingam, Purushothaman, et al.
Publicado: (2021)

Mass drug administration of ivermectin, diethylcarbamazine, plus albendazole compared with diethylcarbamazine plus albendazole for reduction of lymphatic filariasis endemicity in Papua New Guinea: a cluster-randomised trial
por: Laman, Moses, et al.
Publicado: (2022)

A diagnostic protocol designed for determining allergic causes in patients with blood eosinophilia
por: Magnaval, Jean-François, et al.
Publicado: (2017)

LC–MS/MS method for simultaneous determination of diethylcarbamazine, albendazole and albendazole metabolites in human plasma: Application to a clinical pharmacokinetic study
por: Chhonker, Yashpal S., et al.
Publicado: (2018)

Toxocariasis After Slug Ingestion Characterized by Severe Neurologic, Ocular, and Pulmonary Involvement
por: Fellrath, Jean-Marc, et al.
Publicado: (2014)

A Case of Ocular Toxocariasis Successfully Treated with Albendazole and Triamcinolon
por: Seong, San, et al.
Publicado: (2014)

Accelerating the Uptake of WHO Recommendations for Mass Drug Administration Using Ivermectin, Diethylcarbamazine, and Albendazole
por: King, Jonathan D., et al.
Publicado: (2022)

Safety and Tolerability of Mass Diethylcarbamazine and Albendazole Administration for the Elimination of Lymphatic Filariasis in Kenya: An Active Surveillance Study
por: Khaemba, Christabel, et al.
Publicado: (2021)

Epidemiological, Clinical and Laboratory Features of Strongyloidiasis in 69 Attendees at a French Outpatient Clinic
por: Magnaval, Jean-François, et al.
Publicado: (2023)

A randomized, open-label study of the tolerability and efficacy of one or three daily doses of ivermectin plus diethylcarbamazine and albendazole (IDA) versus one dose of ivermectin plus albendazole (IA) for treatment of onchocerciasis
por: Opoku, Nicholas O., et al.
Publicado: (2023)

Efficacy and Safety of a Single Dose of Ivermectin, Diethylcarbamazine, and Albendazole for Treatment of Lymphatic Filariasis in Côte d’Ivoire: An Open-label Randomized Controlled Trial
por: Bjerum, Catherine M, et al.
Publicado: (2019)

Tolerability and efficacy of single dose albendazole, diethylcarbamazine citrate (DEC) or co-administration of albendazole with DEC in the clearance of Wuchereria bancrofti in asymptomatic microfilaraemic volunteers in Pondicherry, South India: a hospital-based study
por: Pani, SP, et al.
Publicado: (2002)

The Impact of Repeated Rounds of Mass Drug Administration with Diethylcarbamazine Plus Albendazole on Bancroftian Filariasis in Papua New Guinea
por: Weil, Gary J., et al.
Publicado: (2008)

Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa
por: Fischer, Peter U., et al.
Publicado: (2017)

Pharmacokinetics, safety, and efficacy of a single co-administered dose of diethylcarbamazine, albendazole and ivermectin in adults with and without Wuchereria bancrofti infection in Côte d’Ivoire
por: Edi, Constant, et al.
Publicado: (2019)

Country Reports on Practical Aspects of Conducting Large-Scale Community Studies of the Tolerability of Mass Drug Administration with Ivermectin/Diethylcarbamazine/Albendazole for Lymphatic Filariasis
por: Jambulingam, Purushothaman, et al.
Publicado: (2022)

Lessons Learned from the Japanese Encephalitis Vaccine Introduction in India That Supported the Introduction of Ivermectin–Diethylcarbamazine–Albendazole for Lymphatic Filariasis Elimination
por: Ghosh, Raj Shankar, et al.
Publicado: (2022)

Diethylcarbamazine and Non-Diethylcarbamazine Related Bancroftian Granuloma: An Immunohistochemical Study of Eosinophil Toxic Proteins
por: Figueredo-Silva, Jose, et al.
Publicado: (2010)

A serological survey of echinococcosis, toxocariasis and trichinellosis among rural inhabitants of Central Yakutia
por: Nakhodkin, Sergey S., et al.
Publicado: (2019)

Impact of two rounds of mass drug administration using diethylcarbamazine combined with albendazole on the prevalence of Brugia timori and of intestinal helminths on Alor Island, Indonesia
por: Oqueka, Tim, et al.
Publicado: (2005)

Safety and efficacy of co-administered diethylcarbamazine, albendazole and ivermectin during mass drug administration for lymphatic filariasis in Haiti: Results from a two-armed, open-label, cluster-randomized, community study
por: Dubray, Christine L., et al.
Publicado: (2020)

The safety of combined triple drug therapy with ivermectin, diethylcarbamazine and albendazole in the neglected tropical diseases co-endemic setting of Fiji: A cluster randomised trial
por: Hardy, Myra, et al.
Publicado: (2020)

Diethylcarbamazine as potential treatment of COVID-19 lung fibrosis
por: Medina-De la Garza, Carlos Eduardo, et al.
Publicado: (2022)

Safety and efficacy of mass drug administration with a single-dose triple-drug regimen of albendazole + diethylcarbamazine + ivermectin for lymphatic filariasis in Papua New Guinea: An open-label, cluster-randomised trial
por: Tavul, Livingstone, et al.
Publicado: (2022)

Frequency of Toxocariasis among Patients Clinically Suspected to Have Visceral Toxocariasis: A Retrospective Descriptive Study in Sri Lanka
por: Iddawela, Devika, et al.
Publicado: (2017)

Schistosomiasis Haematobium, Corsica, France
por: Berry, Antoine, et al.
Publicado: (2014)

Ocular Toxocariasis
por: Pivetti-Pezzi, Paola
Publicado: (2009)

Toxocariasis of the eye
por: Tao, Zui, et al.
Publicado: (2017)

Efficacy and reinfection with soil-transmitted helminths 18-weeks post-treatment with albendazole-ivermectin, albendazole-mebendazole, albendazole-oxantel pamoate and mebendazole
por: Speich, Benjamin, et al.
Publicado: (2016)

Abdominal Mass Secondary to Human Toxocariasis
por: Ghoroobi, Javad, et al.
Publicado: (2017)

Toxocariasis Presenting as Encephalomyelitis
por: Helsen, Gregory, et al.
Publicado: (2011)

Clinical, Laboratory Characteristic, and Treatment of Human Toxocariasis in Northern Vietnam
por: Thu, Huong Nguyen, et al.
Publicado: (2022)

A case of follicular cystitis treated successfully with diethylcarbamazine
por: Sagara Ruwan Kumara, Maduwe Gedara, et al.
Publicado: (2021)

Effect of diethylcarbamazine on testing serum samples for retroviral antibodies
por: Kitchen, L.W., et al.
Publicado: (1988)

The Diethylcarbamazine Delays and Decreases the NETosis of Polymorphonuclear Cells of Humans with DM Type 2
por: Segoviano-Ramirez, Juan C., et al.
Publicado: (2020)

Diethylcarbamazine citrate-fortified salt for lymphatic filariasis elimination in India
por: Sabesan, S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sasnt757tgabbqs3hrre8ik0fl